hrp0098p3-142 | GH and IGFs | ESPE2024

Growth Hormone and Scoliosis; Cause or Coincidence?

Alzahrani Hajer , Alkhuzaei Hisham , Attia Najya , Al Mutair Angham

Introduction: Growth hormone therapy has been approved in the management of short stature secondary to various causes for many years. The safety of growth hormone therapy is questioned in different aspects, one of which is scoliosis development or progression.Cases: We are reporting two cases addressing the concerns of scoliosis and growth hormone (GH) therapy.First case: A 12 year...

hrp0084p3-1072 | Hypo | ESPE2015

Failure of Sirolimus Response on Three More Cases with a Diffuse Type of Congenital Hyperinsulinism

al Mutair Angham , Al BALWI Rana , al Otaibi Ahlam , Atawi Mohsen

Background: Congenital hyperinsulinism (CHI) represent a group of clinically and genetically heterogonous disorder that characterized by unregulated insulin secretion by B-cells. It is the most common cause of hypoglycaemia in the neonatal period. Infants with diffuse CHI have homozygous or compound heterozygous mutation in the KATP channel and the majority are unresponsive to standard medical therapy and eventually they need near total pancreatectomy. Recent data showed the e...

hrp0089p3-p324 | Sex Differentiation, Gonads and Gynaecology or Sex Endocrinology P3 | ESPE2018

Challenges in Managing 46, XY Partial Gonadal Dysgenesis in Saudi Arabia

Babiker Amir , Bin Afif Yassir , Dubayee Mohammed Al , Juraibah Fahad Al , Atawi Mohsen Al , Mutair Angham Al , Alwan Ibrahim Al

Background: Partial gonadal dysgenesis is a rare 46, XY Disorder of sex development (DSD) characterized by a varying degree of testicular dysgenesis, ambiguous genitalia, and persistence or absence of regression of Müllerian structures. Many studies examined the challenges in presentation and gender assignment regarding the genital features, genetic mutations and histopathological risks of dysgenetic gonads. More recently some studies described the long-term outcome of pa...

hrp0098p3-74 | Diabetes and Insulin | ESPE2024

Establishing the Saudi Pediatric & Youth Diabetes Registry (SPYDR): initial data and challenges

Al Dubayee Mohammed , Al Juraibah Fahad , Babiker Amir , Alfaraidi Haifa , Aldahash Raed , Attia Najya , Al Shaikh Adnan , Habeb Abdelhadi , Al Jabri Aida , Al Zaben Abdullah , Al Atawi Mohsen , Al Mutair Angham , Alamri Muhammed , Aldibasi Omer , Al Alwan Ibrahim , Alghnam Suliman

Introduction: The Saudi National Diabetes Registry focuses mainly on adult patients. In 2020, the National Guard Health Authority (NGHA) launched the Saudi Pediatric and Youth Diabetes Registry (SPYDR), for children and adolescents with diabetes. We report on the first data and the challenges we faced during SPYDR initiation.Methods: Patients were identified from the electronic medical records of the Saudi NGHA hospitals...